Biotransformation using genetically modified Candida
US9359581B2 · kind B2 · utility
1Cited by
1References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2013 |
| Grant date | Jun 7, 2016 |
| Priority date | — |
| Expiry date | Nov 19, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/52
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A substantially pure Candida host cell is provided for the biotransformation of a substrate to a product wherein the host cell is characterized by a first genetic modification class that comprises one or more genetic modifications that collectively or individually disrupt at least one alcohol dehydrogenase gene in the substantially pure Candida host cell.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.